Insmed (INSM) News Today $72.51 -0.24 (-0.33%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Insmed Incorporated (NASDAQ:INSM) Short Interest Up 18.7% in DecemberInsmed Incorporated (NASDAQ:INSM - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 15,440,000 shares, an increase of 18.7% from the December 15th total of 13,010,000 shares. Based on an average trading volume of 1,550,000 shares, the short-interest ratio is presently 10.0 days.January 19 at 1:21 PM | marketbeat.comIs Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?January 18 at 6:30 PM | insidermonkey.comInsmed Incorporated (NASDAQ:INSM) Insider Martina M.D. Flammer Sells 1,384 SharesJanuary 17 at 6:42 AM | insidertrades.comHennion & Walsh Asset Management Inc. Lowers Holdings in Insmed Incorporated (NASDAQ:INSM)Hennion & Walsh Asset Management Inc. lowered its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 49.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,934 shares of the biopharmacJanuary 17 at 5:34 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. trimmed its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 38.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 525,193January 17 at 4:09 AM | marketbeat.comInsmed COO Roger Adsett sells $100,125 in stockJanuary 16, 2025 | msn.comInsmed chief medical officer sells $95,108 in stockJanuary 16, 2025 | msn.comInsmed Incorporated (NASDAQ:INSM) Insider Sells $95,108.48 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) insider Martina M.D. Flammer sold 1,384 shares of the business's stock in a transaction dated Tuesday, January 14th. The stock was sold at an average price of $68.72, for a total value of $95,108.48. Following the sale, the insider now owns 100,165 shares in the company, valued at $6,883,338.80. The trade was a 1.36 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.January 16, 2025 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) COO Sells 1,457 Shares of StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) COO Roger Adsett sold 1,457 shares of the firm's stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $68.72, for a total value of $100,125.04. Following the transaction, the chief operating officer now owns 146,082 shares in the company, valued at approximately $10,038,755.04. The trade was a 0.99 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.January 16, 2025 | marketbeat.comGoldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been AlertJanuary 16, 2025 | msn.comInsmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 31,805 Shares of StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 31,805 shares of the business's stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $70.18, for a total transaction of $2,232,074.90. Following the transaction, the chief executive officer now owns 379,534 shares of the company's stock, valued at approximately $26,635,696.12. This represents a 7.73 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.January 16, 2025 | marketbeat.comInsmed’s gene therapy poised to challenge DMD landscape after IND clearanceJanuary 16, 2025 | finance.yahoo.comInsmed’s Strong Performance and Strategic Developments Drive Buy RatingJanuary 15, 2025 | markets.businessinsider.comCapital CS Group LLC Makes New Investment in Insmed Incorporated (NASDAQ:INSM)Capital CS Group LLC purchased a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,488 shares of the biopharmaceutical company's stock,January 14, 2025 | marketbeat.comWhy INSM Stock Is Advancing TodayJanuary 14, 2025 | msn.comInsmed (NASDAQ:INSM) Stock Price Up 6% - Should You Buy?Insmed (NASDAQ:INSM) Stock Price Up 6% - Still a Buy?January 13, 2025 | marketbeat.comTruist Financial Remains a Buy on Insmed (INSM)January 13, 2025 | markets.businessinsider.comInsmed (INSM) Gets a Buy from Evercore ISIJanuary 13, 2025 | markets.businessinsider.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) Insider Sells $220,403.04 in StockJanuary 13, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) COO Sells $312,159.36 in StockJanuary 13, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) CFO Sara Bonstein Sells 3,470 SharesJanuary 13, 2025 | americanbankingnews.comWilliam Lewis Sells 8,218 Shares of Insmed Incorporated (NASDAQ:INSM) StockJanuary 13, 2025 | americanbankingnews.com**Insmed Incorporated to Present at J.P. Morgan Healthcare Conference**January 13, 2025 | americanbankingnews.comInsmed’s Strong Growth Prospects and Strategic Advances Drive Buy RatingJanuary 11, 2025 | markets.businessinsider.comInsmed’s Promising Growth Prospects and Strong Pipeline Justify Buy RatingJanuary 11, 2025 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in StockJanuary 11, 2025 | insidertrades.comHarbor Capital Advisors Inc. Increases Holdings in Insmed Incorporated (NASDAQ:INSM)Harbor Capital Advisors Inc. increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 237.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 59,600 shares of the biopharmaceutical company's stock after purchasJanuary 11, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Insmed (INSM)January 11, 2025 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CFO Sara Bonstein sold 1,066 shares of the firm's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $63.72, for a total value of $67,925.52. Following the completion of the sale, the chief financial officer now owns 118,863 shares of the company's stock, valued at approximately $7,573,950.36. This trade represents a 0.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.January 10, 2025 | marketbeat.comRoger Adsett Sells 2,444 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) COO Roger Adsett sold 2,444 shares of the company's stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $65.95, for a total value of $161,181.80. Following the completion of the transaction, the chief operating officer now directly owns 147,666 shares in the company, valued at approximately $9,738,572.70. This trade represents a 1.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.January 10, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CEO Sells $188,686.08 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 2,978 shares of the business's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $63.36, for a total value of $188,686.08. Following the transaction, the chief executive officer now owns 392,589 shares of the company's stock, valued at $24,874,439.04. This represents a 0.75 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.January 10, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Insider Sells $220,403.04 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) insider Martina M.D. Flammer sold 3,344 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $65.91, for a total value of $220,403.04. Following the completion of the transaction, the insider now directly owns 102,766 shares in the company, valued at approximately $6,773,307.06. This trade represents a 3.15 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.January 10, 2025 | marketbeat.comSara Bonstein Sells 3,470 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CFO Sara Bonstein sold 3,470 shares of the company's stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $65.70, for a total value of $227,979.00. Following the completion of the sale, the chief financial officer now owns 114,736 shares in the company, valued at $7,538,155.20. The trade was a 2.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.January 10, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) COO Roger Adsett Sells 4,902 SharesInsmed Incorporated (NASDAQ:INSM - Get Free Report) COO Roger Adsett sold 4,902 shares of the stock in a transaction on Friday, January 10th. The shares were sold at an average price of $63.68, for a total value of $312,159.36. Following the completion of the transaction, the chief operating officer now directly owns 147,539 shares of the company's stock, valued at approximately $9,395,283.52. This represents a 3.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.January 10, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Insider Martina M.D. Flammer Sells 6,172 SharesInsmed Incorporated (NASDAQ:INSM - Get Free Report) insider Martina M.D. Flammer sold 6,172 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $63.64, for a total transaction of $392,786.08. Following the sale, the insider now owns 101,549 shares in the company, valued at $6,462,578.36. This trade represents a 5.73 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.January 10, 2025 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 8,218 Shares of StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 8,218 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $66.02, for a total value of $542,552.36. Following the sale, the chief executive officer now owns 376,742 shares in the company, valued at approximately $24,872,506.84. This trade represents a 2.13 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.January 10, 2025 | marketbeat.comInsmed issues preliminary revenue results, guidance for ArikayceJanuary 10, 2025 | msn.comInsmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 10, 2025 | prnewswire.comInsmed Incorporated (NASDAQ:INSM) Receives $83.67 Average PT from AnalystsJanuary 10, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) Receives Consensus Rating of "Buy" from AnalystsInsmed Incorporated (NASDAQ:INSM - Get Free Report) has been given an average recommendation of "Buy" by the sixteen analysts that are covering the stock, Marketbeat reports. Sixteen investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that havJanuary 7, 2025 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Insmed (INSM)January 6, 2025 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 18,750 SharesJanuary 4, 2025 | insidertrades.comWilliam Lewis Sells 18,750 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of Insmed stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $69.84, for a total value of $1,309,500.00. Following the completion of the transaction, the chief executive officer now owns 384,960 shares in the company, valued at $26,885,606.40. The trade was a 4.64 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.January 3, 2025 | marketbeat.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 3, 2025 | prnewswire.comInsmed To Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | prnewswire.comIs Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?December 23, 2024 | insidermonkey.comIs Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?December 23, 2024 | msn.comPrincipal Financial Group Inc. Has $136.65 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Principal Financial Group Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,871,890 shares of the biopharmaceutical companDecember 21, 2024 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 18,750 Shares of StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $69.91, for a total value of $1,310,812.50. Following the completion of the transaction, the chief executive officer now owns 384,960 shares in the company, valued at approximately $26,912,553.60. This represents a 4.64 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.December 20, 2024 | marketbeat.comTidal Investments LLC Buys 19,696 Shares of Insmed Incorporated (NASDAQ:INSM)Tidal Investments LLC boosted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 447.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,102 shares of the biopharmaceutical company's stock after purDecember 18, 2024 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.410.44▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼188▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Royalty Pharma News Today BeiGene News Today United Therapeutics News Today Summit Therapeutics News Today Genmab A/S News Today Viatris News Today Intra-Cellular Therapies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
